BibSonomy :: user :: kanefendt

Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal--part II

P. Hubert, J. J. Nguyen-Huu, B. Boulanger, E. Chapuzet, P. Chiap, N. Cohen, P. A. Compagnon, W. Dewe, M. Feinberg, M. Lallier, M. Laurentie, N. Mercier, G. Muzard, C. Nivet, L. Valat, and E. Rozet. J.Pharm.Biomed.Anal. 45(1):70-81 (2007)

3 years and 3 months ago

by kanefendt

1

(0)

URLDOITeX

Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal--part III

P. Hubert, J. J. Nguyen-Huu, B. Boulanger, E. Chapuzet, N. Cohen, P. A. Compagnon, W. Dewe, M. Feinberg, M. Laurentie, N. Mercier, G. Muzard, L. Valat, and E. Rozet. J.Pharm.Biomed.Anal. 45(1):82-96 (2007)

3 years and 3 months ago

by kanefendt

1

(0)

URLDOITeX

Key elements of bioanalytical method validation for macromolecules

M. Kelley, and B. DeSilva. AAPS.J. 9(2):E156-E163 (2007)

3 years and 3 months ago

by kanefendt

1

(0)

URLDOITeX

Sunitinib efficacy against advanced renal cell carcinoma

R. J. Motzer, M. D. Michaelson, J. Rosenberg, R. M. Bukowski, B. D. Curti, D. J. George, G. R. Hudes, B. G. Redman, K. A. Margolin, and G. Wilding. J.Urol. 178(5):1883-1887 (2007)

3 years and 3 months ago

by kanefendt

1

(0)

URLDOITeX

Best practices during bioanalytical method validation for the characterization of assay reagents and the evaluation of analyte stability in assay standards, quality controls, and study samples

W. Nowatzke, and E. Woolf. AAPS.J. 9(2):E117-E122 (2007)

3 years and 3 months ago

by kanefendt

1

(0)

URLDOITeX

Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib

T. F. Chu, M. A. Rupnick, R. Kerkela, S. M. Dallabrida, D. Zurakowski, L. Nguyen, K. Woulfe, E. Pravda, F. Cassiola, J. Desai, S. George, J. A. Morgan, D. M. Harris, N. S. Ismail, J. H. Chen, F. J. Schoen, A. D. van den Abbeele, G. D. Demetri, T. Force, and M. H. Chen. Lancet 370(9604):2011-2019 (2007)

3 years and 3 months ago

by kanefendt

1

& Aged Agents Animals Antineoplastic Arteries Artery Blood Carcinoma Coronary Disease Failure Female Gastrointestinal Heart Humans Hypertension Indoles Kinase Kinases Male Mice Middle Multicenter Pressure Protein-Tyrosine Pyrroles Rats Research Retrospective Safety Stroke Stromal Studies Topic Tumors Tyrosine Volume adverse antagonists as blood chemically drug effects induced inhibitors methods therapeutic therapy toxicity use

(0)

URLDOITeX

Appropriate calibration curve fitting in ligand binding assays

J. W. Findlay, and R. F. Dillard. AAPS.J. 9(2):E260-E267 (2007)

3 years and 3 months ago

by kanefendt

1

(0)

URLDOITeX

Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma

S. Juttner, C. Wissmann, T. Jons, M. Vieth, J. Hertel, S. Gretschel, P. M. Schlag, W. Kemmner, and M. Hocker. J.Clin.Oncol. 24(2):228-240 (2006)

3 years and 3 months ago

by kanefendt

1

(0)

URLDOITeX

Measurement of plasma levels of vascular endothelial growth factor in prostate cancer patients: relationship with clinical stage, Gleason score, prostate volume, and serum prostate-specific antigen

J. L. Duque, K. R. Loughlin, R. M. Adam, P. Kantoff, E. Mazzucchi, and M. R. Freeman. Clinics. 61(5):401-408 (2006)

3 years and 3 months ago

by kanefendt

1

(0)

URLDOITeX

Isolation and enumeration of circulating endothelial cells by immunomagnetic isolation: proposal of a definition and a consensus protocol

A. Woywodt, A. D. Blann, T. Kirsch, U. Erdbruegger, N. Banzet, M. Haubitz, and F. gnat George. J.Thromb.Haemost. 4(3):671-677 (2006)

3 years and 3 months ago

by kanefendt

1

(0)

URLDOITeX

Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients

S. Nadar, A. D. Blann, and G. Y. Lip. Am.J.Hypertens. 19(9):970-977 (2006)

3 years and 3 months ago

by kanefendt

1

(0)

URLDOITeX

Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan

B. Vincenzi, D. Santini, A. Russo, M. Gavasci, F. Battistoni, G. Dicuonzo, L. Rocci, V. M. Rosaria, N. Gebbia, and G. Tonini. Pharmacogenomics. 8(4):319-327 (2007)

3 years and 3 months ago

by kanefendt

1

& A Adult Aged Antibodies Antineoplastic Biological Camptothecin Chemotherapy Colorectal Combined Disease Endothelial Factor Female Growth Humans Male Markers Medical Middle Monoclonal Neoplasms Oncology Outcome Progression Prospective Protocols Rate Studies Survival Treatment Tumor Vascular administration analogs antagonists blood derivatives dosage drug inhibitors methods mortality response therapeutic therapy trends use

(0)

URLDOITeX

Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays

C. T. Viswanathan, S. Bansal, B. Booth, A. J. DeStefano, M. J. Rose, J. Sailstad, V. P. Shah, J. P. Skelly, P. G. Swann, and R. Weiner. Pharm.Res. 24(10):1962-1973 (2007)

3 years and 3 months ago

by kanefendt

1

(0)

URLDOITeX

Critical ligand binding reagent preparation/selection: when specificity depends on reagents

B. Rup, and D. O'Hara. AAPS.J. 9(2):E148-E155 (2007)

3 years and 3 months ago

by kanefendt

1

(0)

URLDOITeX

Workshop/Conference Report - Quantitative Bioanalytical Methods Validation and Implementation: Best Practices for Chromatographic and Ligand binding Assays

Bansal SBooth BDeStefano AJRose MJSailstad JShah VPSkelly JPSwann PGWeiner R. Viswanathan CT. The AAPS Journal 9(1):E30-E42 (2007)

3 years and 3 months ago

by kanefendt

1

Binding Ligand assays binding methods

(0)

URLDOITeX

Effect of treatment with sunitinib malate, a multitargeted tyrosine kinase inhibitor, on circulating plasma levels of VEGF, soluble VEGF receptors 2 and 3, and soluble KIT in patients with metastatic breast cancer

S. E. Deprimo, C. Friece, X. Huang, J. Smeraglia, L. Sherman, M. Collier, C. Baum, A. D. Elias, H. J. Burstein, and K. D. Miller. J Clin Oncol Meeting Abstracts 24(18_suppl):578 (2006)

3 years and 3 months ago

by kanefendt

1

Outcome Proteins Research SU11248 Treatment Tyrosine analysis methods protein response therapy

(0)

URLDOITeX

Validation of analytic methods for biomarkers used in drug development

C. H. Chau, O. Rixe, H. McLeod, and W. D. Figg. Clin.Cancer Res. 14(19):5967-5976 (2008)

3 years and 3 months ago

by kanefendt

1

(0)

URLDOITeX

Biomarker method validation in anticancer drug development

J. Cummings, T. H. Ward, A. Greystoke, M. Ranson, and C. Dive. Br.J.Pharmacol. 153(4):646-656 (2008)

3 years and 3 months ago

by kanefendt

1

& Adherence Agents Animals Antineoplastic Assay Biomarkers Cell Clinical Control Death Drug Enzyme-Linked Europe Evaluation Guideline Guidelines Humans Immunosorbent Keratin-18 Laboratories Mass Pharmacological Preclinical Proteins Quality Reproducibility Research Results Spectrometry Terminology Topic Trials analysis as drug effects jurisprudence legislation methods of pharmacology protein standards therapeutic use

(0)

URLDOITeX

Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane

H. J. Burstein, A. D. Elias, H. S. Rugo, M. A. Cobleigh, A. C. Wolff, P. D. Eisenberg, M. Lehman, B. J. Adams, C. L. Bello, S. E. Deprimo, C. M. Baum, and K. D. Miller. J Clin Oncol 26(11):1810-1816 (2008)

3 years and 3 months ago

by kanefendt

1

& Administration Adult Aged Agents Anthracyclines Antineoplastic Biological Breast Bridged Carcinoma Chemotherapy Combined Compounds Diseases Drug Fatigue Female Gastrointestinal Growth Hematologic Humans Indoles Inflammation Kinase Kinases Markers Middle Neoplasms Oral Plasma Protein-Tyrosine Protocols Pyrroles Rate Schedule Survival Taxoids Tumor Tyrosine administration adverse analysis antagonists blood chemically classification dosage drug effects induced inhibitors methods mortality response secondary therapeutic therapy use

(0)

URLDOITeX

bookmarks

publications (76)